A sponsor needed 60 qualified sites. LINEA delivered 76, with 50% of CDAs and feasibility questionnaires completed within seven days of outreach.
Read the Case StudyAI Playbook & Resources
Practical guidance on using data and AI tools to accelerate site selection, improve feasibility outcomes, and reduce startup timelines.
Featured Resource
A practical, step-by-step framework for integrating AI and data tools into your site selection workflow. Covers protocol configuration, site scoring, feasibility automation, and startup compression strategies used by leading sponsors.
Download the PlaybookCase Studies
A sponsor needed 60 qualified sites. LINEA delivered 76, with 50% of CDAs and feasibility questionnaires completed within seven days of outreach.
Read the Case StudyWith a target of 10 sites and a narrow vaccine-naive eligibility requirement, LINEA identified 12 qualified sites and cut document turnaround time in half.
Read the Case StudyA cardiovascular sponsor needed sites with ACS trial experience across a compressed timeline. LINEA delivered 65 qualified sites with a 2-to-3-day document turnaround.
Read the Case StudyFor a rare hepatology indication with strict eligibility criteria, LINEA identified 21 sites against a target of 20. Eighteen were approved for Protocol Site Visits.
Read the Case StudyGuides & Playbooks
Answers to the most common operational questions sponsors and site teams have about AcceleTrial workflow, document handling, and activation steps.
Read the GuideA 5-step framework for evaluating, piloting, and scaling AI across the clinical trial workflow. Covers governance, use case selection, pilot design, and enterprise-wide integration.
Read the PlaybookA partnership-first, AI-enabled framework for identifying, activating, and supporting clinical trial sites across the study lifecycle, from feasibility through enrollment support.
Read the PrimerA unified, end-to-end model, Audit, Activate, Accelerate, Amplify, and Augment, that sponsors, CROs, and research organizations use to modernize their operations with AI.
Read the BlueprintWhat the FDA move to real-time clinical trials changes about site selection: the pilot timeline, the workflow before and after, the EHR question, six feasibility questions to add now, and what the agency has not answered yet.
Read the BriefingA practical framework for quantifying the cost of poor site selection and calculating the ROI of data-driven approaches, built for budget conversations and leadership presentations.
Read the GuideBrowse by Topic